April 02, 2021
1 min read
Save
Scott Dunbar named as acting CEO of Second Sight
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
The board of directors of Second Sight Medical Products has named Scott Dunbar as acting CEO, according to a press release.
Dunbar, senior patent counsel and compliance officer, has been with the company for 19 years and replaces Matthew Pfeffer, who will remain on Second Sight’s board as an independent director. Pfeffer was named as acting CEO in 2020 but could not remain in the position for more than 1 year under Nasdaq rules.
“I want to thank Matt for his leadership during this past year,” Gregg Williams, chairman of the board, said in the release. “Our focus remains on advancing the Orion program toward providing useful vision to the blind, and I look forward to working with Scott as we pursue that goal.”
Published by:
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.